Literature DB >> 23131395

US screening for detection of nonpalpable locoregional recurrence after mastectomy.

Jin Hwa Lee1, Eun-Kyung Kim, Jong Young Oh, Hyuk-Chan Kwon, Seong Hwan Kim, Dae Cheol Kim, Miri Lee, Se Heon Cho, Kyung Jin Nam.   

Abstract

PURPOSE: To assess the value of screening ultrasonography (US) in the detection of nonpalpable locoregional recurrence following mastectomy for breast cancer and to describe the US appearances of occult recurrent cancers.
MATERIALS AND METHODS: During a 36-month period, 1180 consecutive US screenings were performed for mastectomy sites and ipsilateral axillary fossae in 468 asymptomatic women who had undergone mastectomy for breast cancer. All US results were divided into three groups: negative findings, probably benign nodules, and suspicious for malignant nodules. The final diagnoses were based on pathology results and clinical or sonographic follow-up for more than 12 months. The diagnostic performance of US for detecting nonpalpable locoregional recurrence was assessed. The US appearances of occult recurrent cancers were retrospectively reviewed.
RESULTS: Of the 468 patients assessed, 19 (4.1%) showed "suspicious for malignant nodules"; of these lesions, 10 were malignant. One false-negative case was identified. The sensitivity and specificity were 90.9% and 98.0%, respectively. A biopsy positive predictive value of 52.6% was observed. Cancer detection rates were 2.1% with US screenings of mastectomy sites and ipsilateral axillary fossae. The common US features of occult recurrences at the mastectomy sites were irregular shaped, not-circumscribed marginated, and hypoechoic masses with intratumoral vascularities. The most common location was within the deep muscle layer.
CONCLUSION: Although locoregional recurrence infrequently occurs after mastectomy for breast cancer, screening US enables detection of nonpalpable cancer before it can be detected by clinical examination. Routine follow-up US can be advocated for early detection of nonpalpable locoregional recurrent cancer.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23131395     DOI: 10.1016/j.ejrad.2012.10.007

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  6 in total

1.  Palpable Lumps after Mastectomy: Radiologic-Pathologic Review of Benign and Malignant Masses.

Authors:  Rend Al-Khalili; Ali Alzeer; Giang-Kimthi Nguyen; Erin P Crane; Judy H Song; Janice L Jeon; Michael Nellamattathil; Erini V Makariou; Victoria L Mango
Journal:  Radiographics       Date:  2021-05-14       Impact factor: 6.312

Review 2.  Imaging surveillance of patients with breast cancer after primary treatment: current recommendations.

Authors:  Jung Hyun Yoon; Min Jung Kim; Eun-Kyung Kim; Hee Jung Moon
Journal:  Korean J Radiol       Date:  2015-02-27       Impact factor: 3.500

3.  Breast magnetic resonance imaging for surveillance of women with a personal history of breast cancer: outcomes stratified by interval between definitive surgery and surveillance MR imaging.

Authors:  Vivian Youngjean Park; Eun-Kyung Kim; Min Jung Kim; Hee Jung Moon; Jung Hyun Yoon
Journal:  BMC Cancer       Date:  2018-01-22       Impact factor: 4.430

4.  Screening women with a personal history of breast cancer: overview of the evidence on breast imaging surveillance.

Authors:  Nehmat Houssami; Nariya Cho
Journal:  Ultrasonography       Date:  2018-06-07

5.  Diagnostic value of virtual touch tissue quantification for breast lesions with different size.

Authors:  Minghua Yao; Jian Wu; Liling Zou; Guang Xu; Juan Xie; Rong Wu; Huixiong Xu
Journal:  Biomed Res Int       Date:  2014-04-02       Impact factor: 3.411

6.  Breast ultrasound in breast cancer surveillance; incremental cancers found at what cost?

Authors:  Luke Bromley; Jennifer Xu; Su-Wen Loh; Grace Chew; Eddie Lau; Belinda Yeo
Journal:  Breast       Date:  2020-11-11       Impact factor: 4.380

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.